These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 25584655

  • 1. Loss of the preferential control over the striato-nigral direct pathway by striatal NMDA receptors in a rat model of Parkinson's disease.
    Morari M, Fantin M.
    Analyst; 2015 Jun 07; 140(11):3830-9. PubMed ID: 25584655
    [Abstract] [Full Text] [Related]

  • 2. NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways.
    Fantin M, Marti M, Auberson YP, Morari M.
    J Neurochem; 2007 Dec 07; 103(6):2200-11. PubMed ID: 17986236
    [Abstract] [Full Text] [Related]

  • 3. GluN2A and GluN2B NMDA receptor subunits differentially modulate striatal output pathways and contribute to levodopa-induced abnormal involuntary movements in dyskinetic rats.
    Mabrouk OS, Mela F, Calcagno M, Budri M, Viaro R, Dekundy A, Parsons CG, Auberson YP, Morari M.
    ACS Chem Neurosci; 2013 May 15; 4(5):808-16. PubMed ID: 23611155
    [Abstract] [Full Text] [Related]

  • 4. Striatal NTS1 , dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release--a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat.
    Ferraro L, O'Connor WT, Beggiato S, Tomasini MC, Fuxe K, Tanganelli S, Antonelli T.
    Eur J Neurosci; 2012 Jan 15; 35(2):207-20. PubMed ID: 22211865
    [Abstract] [Full Text] [Related]

  • 5. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function.
    Morari M, O'Connor WT, Ungerstedt U, Bianchi C, Fuxe K.
    Neuroscience; 1996 May 15; 72(1):89-97. PubMed ID: 8730708
    [Abstract] [Full Text] [Related]

  • 6. Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease.
    Ochi M, Shiozaki S, Kase H.
    Neuroscience; 2004 May 15; 127(1):223-31. PubMed ID: 15219684
    [Abstract] [Full Text] [Related]

  • 7. Striatal dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors.
    Marti M, Mela F, Bianchi C, Beani L, Morari M.
    J Neurochem; 2002 Nov 15; 83(3):635-44. PubMed ID: 12390525
    [Abstract] [Full Text] [Related]

  • 8. Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned rats.
    Brugnoli A, Pisanò CA, Morari M.
    Neurobiol Dis; 2020 Oct 15; 144():105044. PubMed ID: 32798726
    [Abstract] [Full Text] [Related]

  • 9. Differential effect of NR2A and NR2B subunit selective NMDA receptor antagonists on striato-pallidal neurons: relationship to motor response in the 6-hydroxydopamine model of parkinsonism.
    Fantin M, Auberson YP, Morari M.
    J Neurochem; 2008 Jul 15; 106(2):957-68. PubMed ID: 18435828
    [Abstract] [Full Text] [Related]

  • 10. In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels.
    Mela F, Marti M, Bido S, Cenci MA, Morari M.
    Neurobiol Dis; 2012 Jan 15; 45(1):573-82. PubMed ID: 22001605
    [Abstract] [Full Text] [Related]

  • 11. Zonisamide enhances delta receptor-associated neurotransmitter release in striato-pallidal pathway.
    Yamamura S, Ohoyama K, Nagase H, Okada M.
    Neuropharmacology; 2009 Sep 15; 57(3):322-31. PubMed ID: 19482038
    [Abstract] [Full Text] [Related]

  • 12. Evidence for a striatal NMDA receptor modulation of nigral glutamate release. A dual probe microdialysis study in the awake freely moving rat.
    Morari M, Sbrenna S, Marti M, O'Connor WT, Bianchi C, Fuxe K, Beani L.
    Eur J Neurosci; 1998 May 15; 10(5):1716-22. PubMed ID: 9751143
    [Abstract] [Full Text] [Related]

  • 13. Striatal NMDA receptors gate cortico-pallidal synchronization in a rat model of Parkinson's disease.
    Zold CL, Escande MV, Pomata PE, Riquelme LA, Murer MG.
    Neurobiol Dis; 2012 Jul 15; 47(1):38-48. PubMed ID: 22465187
    [Abstract] [Full Text] [Related]

  • 14. Increased responsivity of glutamate release from the substantia nigra pars reticulata to striatal NMDA receptor blockade in a model of Parkinson's disease. A dual probe microdialysis study in hemiparkinsonian rats.
    Marti M, Sbrenna S, Fuxe K, Bianchi C, Beani L, Morari M.
    Eur J Neurosci; 2000 May 15; 12(5):1848-50. PubMed ID: 10792462
    [Abstract] [Full Text] [Related]

  • 15. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
    Zeevalk GD, Manzino L, Sonsalla PK.
    Exp Neurol; 2000 Feb 15; 161(2):638-46. PubMed ID: 10686083
    [Abstract] [Full Text] [Related]

  • 16. Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
    Marti M, Manzalini M, Fantin M, Bianchi C, Della Corte L, Morari M.
    J Neurochem; 2005 Apr 15; 93(1):195-205. PubMed ID: 15773919
    [Abstract] [Full Text] [Related]

  • 17. Stimulation of delta opioid receptors located in substantia nigra reticulata but not globus pallidus or striatum restores motor activity in 6-hydroxydopamine lesioned rats: new insights into the role of delta receptors in parkinsonism.
    Mabrouk OS, Volta M, Marti M, Morari M.
    J Neurochem; 2008 Dec 15; 107(6):1647-59. PubMed ID: 19094058
    [Abstract] [Full Text] [Related]

  • 18. The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission.
    Ferraro L, Antonelli T, O'Connor WT, Tanganelli S, Rambert FA, Fuxe K.
    Neurosci Lett; 1998 Sep 04; 253(2):135-8. PubMed ID: 9774168
    [Abstract] [Full Text] [Related]

  • 19. Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels.
    Bido S, Marti M, Morari M.
    J Neurochem; 2011 Sep 04; 118(6):1043-55. PubMed ID: 21740438
    [Abstract] [Full Text] [Related]

  • 20. The novel delta opioid receptor agonist UFP-512 dually modulates motor activity in hemiparkinsonian rats via control of the nigro-thalamic pathway.
    Mabrouk OS, Marti M, Salvadori S, Morari M.
    Neuroscience; 2009 Dec 01; 164(2):360-9. PubMed ID: 19729051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.